Clinical TrialsSearch results
Number of results: 323
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A study to find the best dose of fezolinetant to treat hot flashes in women going through menopause
- Hot Flush
- Wang Xuegong
- 2021-09-22
Other
- MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
- relapsed/refractory multiple myeloma
- Kawai Norisuke
- 2021-08-06
Not yet recruiting
- Skin testing and BAT in healthy volunteers
- Anaphylaxis
- Takazawa Tomonori
- 2021-07-09
Recruiting
- The safety and feasibility of early postoperative chest tube removal after video assisted thoracoscopic lung segmentectomy
- Primary lung cancer, Metastatic lung tumor, inflammatory lung disease
- Hitoshi Igai
- 2021-06-28
Other
- A Phase 2 Study to Evaluate the Efficacy and Safety of BPN14770 in Participants with Mild Alzheimer's Disease
- mild Alzheimer's disease
- Nagata - Tsutae
- 2021-06-14
Not yet recruiting
- Efficacy of eye movement desensitization and reprocessing (EMDR) therapy for people with traumatic events and psychiatric symptoms
- a people with traumatic events
- Fukuda Masato
- 2021-06-14
Completed
- Clinical study of ESWT after meniscus repair
- Meniscal longitudinal tear
- Chikuda Hirotaka
- 2021-06-11
Recruiting
- Significance of ICG fluorescence-guided navigation surgery
- Gastric cancer, Esophagogastric junction cancer
- Sano Akihiko
- 2021-06-09
Recruiting
- A Randomised, Double-Blind, Phase III Study of AZD9833 plusPalbociclib versus Anastrozole plus Palbociclib in Patients with ER-Positive HER2-Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
- ER-Positive HER2-Negative Breast Cancer
- Yamaji Shigeyuki
- 2021-04-15
Recruiting
- Beta-Blocker Withdrawal in Heart Failure with Preserved Ejection Fraction and Chronotropic Incompetence (BRILLIANT)
- Heart failure with preserved ejection fraction
- Obokata Masaru
- 2021-04-09